cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome

MeSH: C548016ORPHA: 309854

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome, sourced from HPO and Orphanet clinical annotations.

Hypomimic faceDysarthriaHypertoniaGait disturbanceDystoniaAbnormality of the liverPortal hypertensionMicronodular cirrhosisSplenomegalyPolycythemiaEsophageal varixRigidityBradykinesiaDysdiadochokinesisPostural instabilityHepatomegalyAction tremorAbnormal globus pallidus morphologyElevated circulating hepatic transaminase concentrationPeripheral neuropathyAbnormal blood inorganic cation concentrationAbnormal myelinationAbnormal basal ganglia MRI signal intensityAbnormal transferrin saturationMicrocephalyJaundiceHypertrophic cardiomyopathyAbnormality of coagulationTruncal ataxiaHyperglycinemiaSpastic paraparesisAstrocytosisAbnormality of amino acid metabolismPoor fine motor coordinationProlonged prothrombin timeDecreased circulating ferritin concentrationIncreased total iron binding capacityCopper accumulation in liverDecreased circulating vitamin E concentration

Classification & Codes

MeSH Code

C548016

Orphanet Code

ORPHA:309854
cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome
MeSHC548016
OrphanetORPHA:309854
Treatments0 drug(s)
Symptoms on record39 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO